Impact of baseline glycated haemoglobin, diabetes duration and body mass index on clinical outcomes in the LixiLan-O trial testing a titratable fixed-ratio combination of insulin glargine/lixisenatide (iGlarLixi) vs insulin glargine and lixisenatide monocomponents

Detalhes bibliográficos
Autores: Davies, MJ, Leiter, LA, Guerci, B, Grunberger, G, Ampudia-Blasco, FJ, Yu, C, Stager, W, Niemoeller, E, Souhami, E, Rosenstock, J
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2017
País:España
Recursos:INCLIVA
Repositorio:r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
OAI Identifier:oai:incliva.fundanetsuite.com:p1860
Acesso em linha:https://incliva.portalinvestigacion.com/publicaciones/1860
Access Level:acceso abierto
id ES_a083b7729c6ff4e3d644ca3235b5c6da
oai_identifier_str oai:incliva.fundanetsuite.com:p1860
network_acronym_str ES
network_name_str España
repository_id_str
spelling Impact of baseline glycated haemoglobin, diabetes duration and body mass index on clinical outcomes in the LixiLan-O trial testing a titratable fixed-ratio combination of insulin glargine/lixisenatide (iGlarLixi) vs insulin glargine and lixisenatide monocomponentsDavies, MJLeiter, LAGuerci, BGrunberger, GAmpudia-Blasco, FJYu, CStager, WNiemoeller, ESouhami, ERosenstock, JWILEY2017info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://incliva.portalinvestigacion.com/publicaciones/1860DIABETES OBESITY & METABOLISMISSN: 14628902ISSNe: 14631326reponame:r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVAinstname:INCLIVAInglésinfo:eu-repo/semantics/openAccessoai:incliva.fundanetsuite.com:p18602026-06-07T16:35:31Z
dc.title.none.fl_str_mv Impact of baseline glycated haemoglobin, diabetes duration and body mass index on clinical outcomes in the LixiLan-O trial testing a titratable fixed-ratio combination of insulin glargine/lixisenatide (iGlarLixi) vs insulin glargine and lixisenatide monocomponents
title Impact of baseline glycated haemoglobin, diabetes duration and body mass index on clinical outcomes in the LixiLan-O trial testing a titratable fixed-ratio combination of insulin glargine/lixisenatide (iGlarLixi) vs insulin glargine and lixisenatide monocomponents
spellingShingle Impact of baseline glycated haemoglobin, diabetes duration and body mass index on clinical outcomes in the LixiLan-O trial testing a titratable fixed-ratio combination of insulin glargine/lixisenatide (iGlarLixi) vs insulin glargine and lixisenatide monocomponents
Davies, MJ
title_short Impact of baseline glycated haemoglobin, diabetes duration and body mass index on clinical outcomes in the LixiLan-O trial testing a titratable fixed-ratio combination of insulin glargine/lixisenatide (iGlarLixi) vs insulin glargine and lixisenatide monocomponents
title_full Impact of baseline glycated haemoglobin, diabetes duration and body mass index on clinical outcomes in the LixiLan-O trial testing a titratable fixed-ratio combination of insulin glargine/lixisenatide (iGlarLixi) vs insulin glargine and lixisenatide monocomponents
title_fullStr Impact of baseline glycated haemoglobin, diabetes duration and body mass index on clinical outcomes in the LixiLan-O trial testing a titratable fixed-ratio combination of insulin glargine/lixisenatide (iGlarLixi) vs insulin glargine and lixisenatide monocomponents
title_full_unstemmed Impact of baseline glycated haemoglobin, diabetes duration and body mass index on clinical outcomes in the LixiLan-O trial testing a titratable fixed-ratio combination of insulin glargine/lixisenatide (iGlarLixi) vs insulin glargine and lixisenatide monocomponents
title_sort Impact of baseline glycated haemoglobin, diabetes duration and body mass index on clinical outcomes in the LixiLan-O trial testing a titratable fixed-ratio combination of insulin glargine/lixisenatide (iGlarLixi) vs insulin glargine and lixisenatide monocomponents
dc.creator.none.fl_str_mv Davies, MJ
Leiter, LA
Guerci, B
Grunberger, G
Ampudia-Blasco, FJ
Yu, C
Stager, W
Niemoeller, E
Souhami, E
Rosenstock, J
author Davies, MJ
author_facet Davies, MJ
Leiter, LA
Guerci, B
Grunberger, G
Ampudia-Blasco, FJ
Yu, C
Stager, W
Niemoeller, E
Souhami, E
Rosenstock, J
author_role author
author2 Leiter, LA
Guerci, B
Grunberger, G
Ampudia-Blasco, FJ
Yu, C
Stager, W
Niemoeller, E
Souhami, E
Rosenstock, J
author2_role author
author
author
author
author
author
author
author
author
publishDate 2017
dc.date.none.fl_str_mv 2017
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://incliva.portalinvestigacion.com/publicaciones/1860
url https://incliva.portalinvestigacion.com/publicaciones/1860
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv WILEY
publisher.none.fl_str_mv WILEY
dc.source.none.fl_str_mv DIABETES OBESITY & METABOLISM
ISSN: 14628902
ISSNe: 14631326
reponame:r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname:INCLIVA
instname_str INCLIVA
reponame_str r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
collection r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869415017369042944
score 15.812429

Registos relacionados